Antabio is a Labège, France-based biopharmaceutical company dedicated to the discovery of first-in-class small molecule compounds to treat severe infections caused by antibiotic-resistant bacterial pathogens. Antabio’s novel compounds block the drug-resistance mechanisms and the virulence of pathogenic bacteria by targeting key bacterial pathways. Using its patented technology, antibacterial discovery expertise, and partnering-oriented business strategy, Antabio advances novel drugs that will offer solutions to the shortfall of the current antibacterial arsenal. Antabio is advancing its Pseudomonas elastase inhibitor (PEi) program for the treatment of Pseudomonas aeruginosa infections in Cystic Fibrosis patients towards the clinic which is funded through a grant from CARB-X. This is an innovative inhaled approach targeting a key Pseudomonas virulence factor, intended to be used as an adjunct to antibiotic treatments.
Antabio is seeking a Clinical Pharmacologist to join our R&D team to set up and co-ordinate future clinical trials under the responsibility of our Head of Clinical Development. The position could be full or part-time, depending on the experience of the applicant and the scope of the role they are able to undertake.